start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=91 end-page=93 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=•½¬21”N“x‰ªŽRˆãŠw‰ïÜ‚ªŒˆ‚Ü‚é en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=Okayama Medical Association en-aut-sei=Okayama Medical Association en-aut-mei= kn-aut-name=‰ªŽRˆãŠw‰ï kn-aut-sei=‰ªŽRˆãŠw‰ï kn-aut-mei= aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil= END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=85 end-page=90 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‘æ170‰ñ@‰ªŽRŠO‰È‰ï en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=OharaToshinori en-aut-sei=Ohara en-aut-mei=Toshinori kn-aut-name=‘匴—˜Œ› kn-aut-sei=‘匴 kn-aut-mei=—˜Œ› aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil= END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=83 end-page=84 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“y¯’¬—§“y¯’†‰›•a‰@ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=MiyakeKen-ichi en-aut-sei=Miyake en-aut-mei=Ken-ichi kn-aut-name=ŽO‘ˆê kn-aut-sei=ŽO‘î kn-aut-mei=Œ«ˆê aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=“y¯’¬—§“y¯’†‰›•a‰@ END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=81 end-page=82 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=’¹ŽæŽs—§•a‰@ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TanakaNoriaki en-aut-sei=Tanaka en-aut-mei=Noriaki kn-aut-name=“c’†‹IÍ kn-aut-sei=“c’† kn-aut-mei=‹IÍ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=’¹ŽæŽs—§•a‰@ END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=77 end-page=79 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=IgG4-related disease kn-title=IgG4 ŠÖ˜AŽ¾Š³ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=SatoYasuharu en-aut-sei=Sato en-aut-mei=Yasuharu kn-aut-name=²“¡N° kn-aut-sei=²“¡ kn-aut-mei=N° aut-affil-num=1 ORCID= en-aut-name=YoshinoTadashi en-aut-sei=Yoshino en-aut-mei=Tadashi kn-aut-name=‹g–ì³ kn-aut-sei=‹g–ì kn-aut-mei=³ aut-affil-num=2 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•a—ŠwiŽîᇕa—j affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•a—ŠwiŽîᇕa—j END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=73 end-page=76 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Drug interaction (17. combination with hyperlipidemia) kn-title=–ò•¨‘ŠŒÝì—p(17\Ž‰Ž¿ˆÙíÇŽ¡—Öò‚Ì‘ŠŒÝì—pj en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KawasakiYoichi en-aut-sei=Kawasaki en-aut-mei=Yoichi kn-aut-name=‰Íè—zˆê kn-aut-sei=‰Íè kn-aut-mei=—zˆê aut-affil-num=1 ORCID= en-aut-name=MatsunagaHisashi en-aut-sei=Matsunaga en-aut-mei=Hisashi kn-aut-name=¼‰i® kn-aut-sei=¼‰i kn-aut-mei=® aut-affil-num=2 ORCID= en-aut-name=SendoToshiaki en-aut-sei=Sendo en-aut-mei=Toshiaki kn-aut-name=ç“°”Nº kn-aut-sei=ç“° kn-aut-mei=”Nº aut-affil-num=3 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”EŽ•Šw•”•‘®•a‰@@–òÜ•” affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”EŽ•Šw•”•‘®•a‰@@–òÜ•” affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”EŽ•Šw•”•‘®•a‰@@–òÜ•” END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=67 end-page=71 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The Japanese guideline for management of cervical spondylotis myelopathy kn-title=Œz’ÅÇ«Ò‘Ç‚Ìf—ÃKƒCƒhƒ‰ƒCƒ“ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TanakaMasato en-aut-sei=Tanaka en-aut-mei=Masato kn-aut-name=“c’†‰ël kn-aut-sei=“c’† kn-aut-mei=‰ël aut-affil-num=1 ORCID= en-aut-name=SugimotoYoshihisa en-aut-sei=Sugimoto en-aut-mei=Yoshihisa kn-aut-name=™–{‰À‹v kn-aut-sei=™–{ kn-aut-mei=‰À‹v aut-affil-num=2 ORCID= en-aut-name=MisawaHaruo en-aut-sei=Misawa en-aut-mei=Haruo kn-aut-name=ŽOàVŽ¡•v kn-aut-sei=ŽOàV kn-aut-mei=Ž¡•v aut-affil-num=3 ORCID= en-aut-name=TakahataTomohiro en-aut-sei=Takahata en-aut-mei=Tomohiro kn-aut-name=‚”¨’qG kn-aut-sei=‚”¨ kn-aut-mei=’qG aut-affil-num=4 ORCID= en-aut-name=OzakiToshifumi en-aut-sei=Ozaki en-aut-mei=Toshifumi kn-aut-name=”öú±•q•¶ kn-aut-sei=”öú± kn-aut-mei=•q•¶ aut-affil-num=5 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=61 end-page=65 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Treatment strategy for chronic hepatitis B and C based on the guidelines kn-title=ƒKƒCƒhƒ‰ƒCƒ“‚ÉŠî‚¢‚½‚aŒ^E‚bŒ^–«ŠÌ‰Š‚ÌŽ¡—Õûj en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KobashiHaruhiko en-aut-sei=Kobashi en-aut-mei=Haruhiko kn-aut-name=¬‹´t•F kn-aut-sei=¬‹´ kn-aut-mei=t•F aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŠÌ‘Ÿ“à‰ÈŠw END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=55 end-page=59 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Interventional radiology for vascular anomalies kn-title=ŒŒŠÇŽîEŒŒŠÇŠïŒ`‚ɑ΂·‚éinterventional radiology en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=MimuraHidefumi en-aut-sei=Mimura en-aut-mei=Hidefumi kn-aut-name=ŽO‘ºG•¶ kn-aut-sei=ŽO‘º kn-aut-mei=G•¶ aut-affil-num=1 ORCID= en-aut-name=FujiwaraHiroyasu en-aut-sei=Fujiwara en-aut-mei=Hiroyasu kn-aut-name=“¡Œ´Š°N kn-aut-sei=“¡Œ´ kn-aut-mei=Š°N aut-affil-num=2 ORCID= en-aut-name=HirakiTakao en-aut-sei=Hiraki en-aut-mei=Takao kn-aut-name=•½–Ø—²•v kn-aut-sei=•½–Ø kn-aut-mei=—²•v aut-affil-num=3 ORCID= en-aut-name=GobaraHideo en-aut-sei=Gobara en-aut-mei=Hideo kn-aut-name=‹½Œ´‰p•v kn-aut-sei=‹½Œ´ kn-aut-mei=‰p•v aut-affil-num=4 ORCID= en-aut-name=ShibamotoKentaro en-aut-sei=Shibamoto en-aut-mei=Kentaro kn-aut-name=ŽÅ–{Œ’‘¾˜Y kn-aut-sei=ŽÅ–{ kn-aut-mei=Œ’‘¾˜Y aut-affil-num=5 ORCID= en-aut-name=KimataYoshihiro en-aut-sei=Kimata en-aut-mei=Yoshihiro kn-aut-name=–،Ҍh—T kn-aut-sei=–ØŒÒ kn-aut-mei=Œh—T aut-affil-num=6 ORCID= en-aut-name=OzakiToshifumi en-aut-sei=Ozaki en-aut-mei=Toshifumi kn-aut-name=”öú±•q•¶ kn-aut-sei=”öú± kn-aut-mei=•q•¶ aut-affil-num=7 ORCID= en-aut-name=SasakiSatoru en-aut-sei=Sasaki en-aut-mei=Satoru kn-aut-name=²X–Ø—¹ kn-aut-sei=²X–Ø kn-aut-mei=—¹ aut-affil-num=8 ORCID= en-aut-name=KanazawaSusumu en-aut-sei=Kanazawa en-aut-mei=Susumu kn-aut-name=‹ààV‰E kn-aut-sei=‹ààV kn-aut-mei=‰E aut-affil-num=9 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Œ`¬ÄŒšŠO‰ÈŠw affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@®Œ`ŠO‰ÈŠw affil-num=8 en-affil= kn-affil=“l“ì•a‰@Œ`¬ŠO‰È affil-num=9 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•úŽËüˆãŠw en-keyword=ŒŒŠÇŠïŒ` kn-keyword=ŒŒŠÇŠïŒ` en-keyword=Ö¬ŠïŒ` kn-keyword=Ö¬ŠïŒ` en-keyword=“®Ã–¬ŠïŒ` kn-keyword=“®Ã–¬ŠïŒ` en-keyword=Çðp kn-keyword=Çðp en-keyword=d‰»—Ö@ kn-keyword=d‰»—Ö@ END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=43 end-page=54 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Relationship between the accreditation criteria for disability pensions and work status : Focusing on mental disorders and mental retardation kn-title=áŠQ”N‹à‚Ì”F’èŠî€‚ÆA˜J‚ÌŠÖŒW\¸_áŠQE’m“IáŠQ‚ð’†S‚Æ‚µ‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=This study aims to examine whether work status is the only basis for determining the provision of disability pensions in cases of mental illness, and considers the validity of this criterion and ways to improve the system. We collected 178 decisions of the Examination Committee of Social Insurance due to "Mental Illness" over a period of 11 years (1994 to 2004), and investigated the relationships among three factors : activity of daily living (ADL), work status, and pension benefits. We also examined the 21 working subjects separately. We found a significant relationship between ADL and pension benefits and between work status and pension benefits. No significant relationship was found between ADL and work status. In 6 of the 21 working subjects, the disability pension decision was made solely by focusing on work status. Despite this focus on work status, the working disabled cannot always compensate for their reduced income and the extraordinary expenditure incurred due to their disability. Further, because these decisions can go against the trend of encouraging the disabled to work, we suggest that it is not appropriate to focus solely on work status in determining pension benefits and propose ways to improve the system. en-copyright= kn-copyright= en-aut-name=KoumotoJunko en-aut-sei=Koumoto en-aut-mei=Junko kn-aut-name=‰Í–{ƒŽq kn-aut-sei=‰Í–{ kn-aut-mei=ƒŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@‰uŠwE‰q¶Šw•ª–ì en-keyword=¸_áŠQ (mental disorder) kn-keyword=¸_áŠQ (mental disorder) en-keyword=’m“IáŠQ (mental retardation) kn-keyword=’m“IáŠQ (mental retardation) en-keyword=áŠQ”N‹à (disability pension) kn-keyword=áŠQ”N‹à (disability pension) en-keyword=ŽÐ‰ïŽQ‰Á (social participation) kn-keyword=ŽÐ‰ïŽQ‰Á (social participation) en-keyword=Œö“I”N‹à§“x (national pension plan) kn-keyword=Œö“I”N‹à§“x (national pension plan) END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=39 end-page=42 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=A clinicopathological study of distal bile duct carcinoma at Fukuyama Medical Center kn-title=“–‰@‚É‚¨‚¯‚鉺•”’_ŠÇŠàŽèpÇ—á‚ÌŽ¡—Ã¬Ñ en-subtitle= kn-subtitle= en-abstract= kn-abstract=We experienced 20 patients with distal bile duct carcinoma from May, 1997 to December, 2007. The male/female ratio was 11/9 and the average age was 69.6 years. The operative procedures were as follows : pancreaticoduodenectomy (PD), 9 ; pyrolus preserving pancreaticoduodenectomy (PPPD), 8 ; subtotal stomach preserving pancreaticoduodenectomy (SSPPD), 2 and hepatico-jejunostomy without resection, 1. We performed a clinicopathological study on 16 patients with distal bile duct carcinoma, excluding 3 operation-related deaths and 1 unresectable case. The cumulative survival rate was 70% at 3 years and 11% at 5 years. The 3-year survival rates at fStageII, fStageIVa and fStageIVb were 100%, 80% and 0%, respectively. Log-rank analysis revealed that pathological pancreatic and duodenal invasion and curative resectability may be prognostic factors, while lymph node metastasis and perineural and stump invasion did not affect prognosis. Six recurrences in the 11 curative resection cases (54.5%) were observed ; therefore, postoperative systemic chemotherapy is warranted to curtail recurrence in advanced distal bile duct carcinoma. en-copyright= kn-copyright= en-aut-name=HamanoRyosuke en-aut-sei=Hamano en-aut-mei=Ryosuke kn-aut-name=à_–ì—º•ã kn-aut-sei=à_–ì kn-aut-mei=—º•ã aut-affil-num=1 ORCID= en-aut-name=InagakiMasaru en-aut-sei=Inagaki en-aut-mei=Masaru kn-aut-name=ˆîŠ_—D kn-aut-sei=ˆîŠ_ kn-aut-mei=—D aut-affil-num=2 ORCID= en-aut-name=NishieManabu en-aut-sei=Nishie en-aut-mei=Manabu kn-aut-name=¼]Šw kn-aut-sei=¼] kn-aut-mei=Šw aut-affil-num=3 ORCID= en-aut-name=TokunagaNaoyuki en-aut-sei=Tokunaga en-aut-mei=Naoyuki kn-aut-name=“¿‰i®”V kn-aut-sei=“¿‰i kn-aut-mei=®”V aut-affil-num=4 ORCID= en-aut-name=TsunemitsuYosuke en-aut-sei=Tsunemitsu en-aut-mei=Yosuke kn-aut-name=íŒõ—m•ã kn-aut-sei=íŒõ kn-aut-mei=—m•ã aut-affil-num=5 ORCID= en-aut-name=OhtsukaShinya en-aut-sei=Ohtsuka en-aut-mei=Shinya kn-aut-name=‘å’ËáÁÆ kn-aut-sei=‘å’Ë kn-aut-mei=áÁÆ aut-affil-num=6 ORCID= en-aut-name=IwakawaKazuhide en-aut-sei=Iwakawa en-aut-mei=Kazuhide kn-aut-name=Šâì˜aG kn-aut-sei=Šâì kn-aut-mei=˜aG aut-affil-num=7 ORCID= en-aut-name=IwagakiHiromi en-aut-sei=Iwagaki en-aut-mei=Hiromi kn-aut-name=ŠâŠ_”Ž–¤ kn-aut-sei=ŠâŠ_ kn-aut-mei=”Ž–¤ aut-affil-num=8 ORCID= en-aut-name=SonobeHiroshi en-aut-sei=Sonobe en-aut-mei=Hiroshi kn-aut-name=‰€•”G kn-aut-sei=‰€•” kn-aut-mei=G aut-affil-num=9 ORCID= affil-num=1 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=2 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=3 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=4 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=5 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=6 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=7 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=8 en-affil= kn-affil=‘—§•a‰@‹@\•ŸŽRˆã—ÃZƒ“ƒ^[@ŠO‰È affil-num=9 en-affil= kn-affil=’†‘’†‰›•a‰@@—Õ°ŒŸ¸‰È en-keyword=‰º•”’_ŠÇŠà (distal bile duct carcinoma) kn-keyword=‰º•”’_ŠÇŠà (distal bile duct carcinoma) en-keyword=Žèp (operation) kn-keyword=Žèp (operation) en-keyword=—\Œã‹K’èˆöŽq (independent prognostic factors) kn-keyword=—\Œã‹K’èˆöŽq (independent prognostic factors) END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=33 end-page=38 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Contribution of cell cultures to the Nobel Prize kn-title=×–E”|—{‚̃m[ƒxƒ‹Ü‚Ö‚ÌvŒ£ en-subtitle= kn-subtitle= en-abstract= kn-abstract=–ñ1¢‹I‘O‚É, ¶‚«‚½‘gD‚â×–E‚ð“®•¨‚Ì‘ÌŠO‚ÉŽæ‚èo‚µ‚½Œ¤‹†\‘gD”|—{‚ ‚é‚¢‚Í×–E”|—{\‚ªŽn‚Ü‚Á‚½D‚»‚ÌŒã‚ÌŒ¤‹†‚Ì—¬‚ê‚Ì’†‚Å, 1) ‘gDE×–E”|—{‚Ì“Á«‚𶂩‚µ‚Äs‚í‚ꂽŒ¤‹†‚Ńm[ƒxƒ‹Ü‚É‹P‚¢‚½Œ¤‹†, 2) ‘gDE×–E”|—{‚ÌŒoŒ±‚ð‚à‚ƒm[ƒxƒ‹ÜŽóÜŽÒ, 3) ƒm[ƒxƒ‹Ü‚É‚Í‚È‚ç‚È‚©‚Á‚½‚¯‚ê‚Ç‚à“Á‹L‚Å‚«‚é‚ÆŽ„‚ªl‚¦‚é×–E”|—{‚ÌŒ¤‹†C‚Ȃǂɂ‚¢‚ÄŽæ‚èã‚°‚Ä‚Ý‚½‚¢. en-copyright= kn-copyright= en-aut-name=NambaMasayoshi en-aut-sei=Namba en-aut-mei=Masayoshi kn-aut-name=“ï”g³‹` kn-aut-sei=“ï”g kn-aut-mei=³‹` aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=VŒ©Œö—§‘åŠw en-keyword=×–E kn-keyword=×–E en-keyword=”|—{ kn-keyword=”|—{ en-keyword=ƒm[ƒxƒ‹Ü kn-keyword=ƒm[ƒxƒ‹Ü END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=27 end-page=31 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Aldosterone breakthrough caused by chronic blockage of angiotensin II type 1 receptors in human adrenocortical cells: Possible involvement of bone morphogenetic protein-6 actions kn-title=•›t”玿זE‚É‚¨‚¯‚éƒAƒ‹ƒhƒXƒeƒƒ“ƒuƒŒƒCƒNƒXƒ‹[Œ»Û‚ÆBMP-6‚ÌŠÖ—^ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=OtaniHiroyuki en-aut-sei=Otani en-aut-mei=Hiroyuki kn-aut-name=‘å’JŠ°”V kn-aut-sei=‘å’J kn-aut-mei=Š°”V aut-affil-num=1 ORCID= en-aut-name=OtsukaFumio en-aut-sei=Otsuka en-aut-mei=Fumio kn-aut-name=‘å’Ë•¶’j kn-aut-sei=‘å’Ë kn-aut-mei=•¶’j aut-affil-num=2 ORCID= en-aut-name=MakinoHirofumi en-aut-sei=Makino en-aut-mei=Hirofumi kn-aut-name=ꠖ씎Žj kn-aut-sei=ê –ì kn-aut-mei=”ŽŽj aut-affil-num=3 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw en-keyword=ƒAƒ‹ƒhƒXƒeƒƒ“ƒuƒŒƒCƒNƒXƒ‹[ kn-keyword=ƒAƒ‹ƒhƒXƒeƒƒ“ƒuƒŒƒCƒNƒXƒ‹[ en-keyword=BMP-6 kn-keyword=BMP-6 en-keyword=MAPK kn-keyword=MAPK en-keyword=•›t”玿זE kn-keyword=•›t”玿זE END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=17 end-page=25 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Dual tyrosine kinase inhibitor for focal adhesion kinase and insulin-like growth factor-I receptor exhibits an anticancer effect in esophageal adenocarcinoma in vitro and in vivo kn-title=Focal adhesion kinase (FAK) ‚Æ Insulin-like growth factor-I receptor (IGF-IR) ‚ɑ΂·‚éƒfƒ…ƒAƒ‹ƒ`ƒƒVƒ“ƒLƒi[ƒ[‘jŠQÜ‚ÌH“¹‘BŠà‚É‚¨‚¯‚éRŽîᇌø‰Ê en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=WatanabeNobuyuki en-aut-sei=Watanabe en-aut-mei=Nobuyuki kn-aut-name=“n•ÓM”V kn-aut-sei=“n•Ó kn-aut-mei=M”V aut-affil-num=1 ORCID= en-aut-name=TakaokaMunenori en-aut-sei=Takaoka en-aut-mei=Munenori kn-aut-name=ûü‰ª@“¿ kn-aut-sei=ûü‰ª kn-aut-mei=@“¿ aut-affil-num=2 ORCID= en-aut-name=SakuramaKazufumi en-aut-sei=Sakurama en-aut-mei=Kazufumi kn-aut-name=ŸNŠÔˆêŽj kn-aut-sei=ŸNŠÔ kn-aut-mei=ˆêŽj aut-affil-num=3 ORCID= en-aut-name=TomonoYasuko en-aut-sei=Tomono en-aut-mei=Yasuko kn-aut-name=—F–ì–õŽq kn-aut-sei=—F–ì kn-aut-mei=–õŽq aut-affil-num=4 ORCID= en-aut-name=HatakeyamaShinji en-aut-sei=Hatakeyama en-aut-mei=Shinji kn-aut-name=”©ŽRT“ñ kn-aut-sei=”©ŽR kn-aut-mei=T“ñ aut-affil-num=5 ORCID= en-aut-name=OhmoriOsamu en-aut-sei=Ohmori en-aut-mei=Osamu kn-aut-name=‘åXC kn-aut-sei=‘åX kn-aut-mei=C aut-affil-num=6 ORCID= en-aut-name=MotokiTakayuki en-aut-sei=Motoki en-aut-mei=Takayuki kn-aut-name=Œ³–Ø’”V kn-aut-sei=Œ³–Ø kn-aut-mei=’”V aut-affil-num=7 ORCID= en-aut-name=ShirakawaYasuhiro en-aut-sei=Shirakawa en-aut-mei=Yasuhiro kn-aut-name=”’ì–õ”Ž kn-aut-sei=”’ì kn-aut-mei=–õ”Ž aut-affil-num=8 ORCID= en-aut-name=YamatsujiTomoki en-aut-sei=Yamatsuji en-aut-mei=Tomoki kn-aut-name=ŽR’Ò’mŽ÷ kn-aut-sei=ŽR’Ò kn-aut-mei=’mŽ÷ aut-affil-num=9 ORCID= en-aut-name=HaisaMinoru en-aut-sei=Haisa en-aut-mei=Minoru kn-aut-name=‰Hˆä²ŽÀ kn-aut-sei=‰Hˆä² kn-aut-mei=ŽÀ aut-affil-num=10 ORCID= en-aut-name=MatsuokaJunji en-aut-sei=Matsuoka en-aut-mei=Junji kn-aut-name=¼‰ª‡Ž¡ kn-aut-sei=¼‰ª kn-aut-mei=‡Ž¡ aut-affil-num=11 ORCID= en-aut-name=BeerDavid G. en-aut-sei=Beer en-aut-mei=David G. kn-aut-name= kn-aut-sei= kn-aut-mei= aut-affil-num=12 ORCID= en-aut-name=NagatsukaHitoshi en-aut-sei=Nagatsuka en-aut-mei=Hitoshi kn-aut-name=’·’Ëm kn-aut-sei=’·’Ë kn-aut-mei=m aut-affil-num=13 ORCID= en-aut-name=TanakaNoriaki en-aut-sei=Tanaka en-aut-mei=Noriaki kn-aut-name=“c’†‹IÍ kn-aut-sei=“c’† kn-aut-mei=‹IÍ aut-affil-num=14 ORCID= en-aut-name=NaomotoYoshio en-aut-sei=Naomoto en-aut-mei=Yoshio kn-aut-name=—P–{—Ç•v kn-aut-sei=—P–{ kn-aut-mei=—Ç•v aut-affil-num=15 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=4 en-affil= kn-affil=dˆäˆãŠwŒ¤‹†Š affil-num=5 en-affil= kn-affil=ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}@’}”gŒ¤‹†Š affil-num=6 en-affil= kn-affil=ƒmƒoƒ‹ƒeƒBƒXƒtƒ@[ƒ}@’}”gŒ¤‹†Š affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=8 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=9 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=10 en-affil= kn-affil=‰ªŽRŽs—§Žs–¯•a‰@@ŠO‰È affil-num=11 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=12 en-affil= kn-affil=ƒ~ƒVƒKƒ“‘åŠw@‹¹•”ŠO‰È affil-num=13 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Œûo•a—Šw affil-num=14 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw affil-num=15 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@Á‰»ŠíEŽîᇊO‰ÈŠw en-keyword=focal adhesion kinase (FAK) kn-keyword=focal adhesion kinase (FAK) en-keyword=ƒoƒŒƒbƒgH“¹Šà kn-keyword=ƒoƒŒƒbƒgH“¹Šà en-keyword=FAK‘jŠQÜ kn-keyword=FAK‘jŠQÜ END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=9 end-page=16 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The DNA damage sensors ataxia-telangiectasia mutated kinase and checkpoint kinase 2 are required for hepatitis C virus RNA replication kn-title=DNA ‘¹ƒZƒ“ƒT[ATMƒLƒi[ƒ[‚ÆChk2‚Í‚bŒ^ŠÌ‰ŠƒEƒCƒ‹ƒX‚ÌRNA•¡»‚É•K—v‚Å‚ ‚é en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=AriumiYasuo en-aut-sei=Ariumi en-aut-mei=Yasuo kn-aut-name=—LŠCN—Y kn-aut-sei=—LŠC kn-aut-mei=N—Y aut-affil-num=1 ORCID= en-aut-name=KurokiMisao en-aut-sei=Kuroki en-aut-mei=Misao kn-aut-name=•–Ø”ü¹ kn-aut-sei=•–Ø kn-aut-mei=”ü¹ aut-affil-num=2 ORCID= en-aut-name=DansakoHiromichi en-aut-sei=Dansako en-aut-mei=Hiromichi kn-aut-name=š£”—_•û kn-aut-sei=š£”— kn-aut-mei=_•û aut-affil-num=3 ORCID= en-aut-name=AbeKenichi en-aut-sei=Abe en-aut-mei=Kenichi kn-aut-name=ˆ¢•”Œ’ˆê kn-aut-sei=ˆ¢•” kn-aut-mei=Œ’ˆê aut-affil-num=4 ORCID= en-aut-name=IkedaMasanori en-aut-sei=Ikeda en-aut-mei=Masanori kn-aut-name=’r“c³“¿ kn-aut-sei=’r“c kn-aut-mei=³“¿ aut-affil-num=5 ORCID= en-aut-name=WakitaTakaji en-aut-sei=Wakita en-aut-mei=Takaji kn-aut-name=˜e“c—²Žš kn-aut-sei=˜e“c kn-aut-mei=—²Žš aut-affil-num=6 ORCID= en-aut-name=KatoNobuyuki en-aut-sei=Kato en-aut-mei=Nobuyuki kn-aut-name=‰Á“¡é”V kn-aut-sei=‰Á“¡ kn-aut-mei=é”V aut-affil-num=7 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw affil-num=6 en-affil= kn-affil=‘—§Š´õÇŒ¤‹†Š@ƒEƒCƒ‹ƒX‘æ“ñ•” affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@ŽîᇃEƒCƒ‹ƒXŠw en-keyword=HCV kn-keyword=HCV en-keyword=ATM kn-keyword=ATM en-keyword=Chk2 kn-keyword=Chk2 en-keyword=hŽåˆöŽq kn-keyword=hŽåˆöŽq en-keyword=DNA ‘¹ƒZƒ“ƒT[ kn-keyword=DNA ‘¹ƒZƒ“ƒT[ END start-ver=1.4 cd-journal=joma no-vol=122 cd-vols= no-issue=1 article-no= start-page=1 end-page=7 dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Collectrin is involved in the development of salt-sensitive hypertension by facilitating the membrane trafficking of apical membrane proteins via interaction with soluble n-ethylmaleiamide-sensitive factor attachment protein receptor complex kn-title=ƒRƒŒƒNƒgƒŠƒ“‚ÍSNARE•¡‡‘Ì‚Æ‚Ì‘ŠŒÝì—p‚ð‰î‚µ‚ÄŠÇo‘¤–Œ’`”’‚Ì–Œ—A‘—‚ð‘£i‚µH‰–Š´Žó«‚ŒŒˆ³‚Ì”­Ç‚ÉŠÖ—^‚µ‚Ä‚¢‚é en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=YasuharaAkihiro en-aut-sei=Yasuhara en-aut-mei=Akihiro kn-aut-name=ˆÀŒ´Í_ kn-aut-sei=ˆÀŒ´ kn-aut-mei=Í_ aut-affil-num=1 ORCID= en-aut-name=WadaJun en-aut-sei=Wada en-aut-mei=Jun kn-aut-name=˜a“c~ kn-aut-sei=˜a“c kn-aut-mei=~ aut-affil-num=2 ORCID= en-aut-name=EguchiJun en-aut-sei=Eguchi en-aut-mei=Jun kn-aut-name=]Œû kn-aut-sei=]Œû kn-aut-mei= aut-affil-num=3 ORCID= en-aut-name=NakatsukaAtsuko en-aut-sei=Nakatsuka en-aut-mei=Atsuko kn-aut-name=’†Ži“ÖŽq kn-aut-sei=’†Ži kn-aut-mei=“ÖŽq aut-affil-num=4 ORCID= en-aut-name=MurakamiKazutoshi en-aut-sei=Murakami en-aut-mei=Kazutoshi kn-aut-name=‘ºã˜a•q kn-aut-sei=‘ºã kn-aut-mei=˜a•q aut-affil-num=5 ORCID= en-aut-name=KanzakiMotoko en-aut-sei=Kanzaki en-aut-mei=Motoko kn-aut-name=_莑Žq kn-aut-sei=_è kn-aut-mei=Ž‘Žq aut-affil-num=6 ORCID= en-aut-name=TeshigawaraSanae en-aut-sei=Teshigawara en-aut-mei=Sanae kn-aut-name=’ºŽg쌴‘•c kn-aut-sei=’ºŽg쌴 kn-aut-mei=‘•c aut-affil-num=7 ORCID= en-aut-name=MakinoHirofumi en-aut-sei=Makino en-aut-mei=Hirofumi kn-aut-name=ꠖ씎Žj kn-aut-sei=ê –ì kn-aut-mei=”ŽŽj aut-affil-num=8 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw affil-num=8 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@tE–ƉuE“à•ª”å‘ãŽÓ“à‰ÈŠw en-keyword=H‰–Š´Žó«‚ŒŒˆ³ kn-keyword=H‰–Š´Žó«‚ŒŒˆ³ en-keyword=ƒRƒŒƒNƒgƒŠƒ“ kn-keyword=ƒRƒŒƒNƒgƒŠƒ“ en-keyword=W‡ŠÇ kn-keyword=W‡ŠÇ en-keyword=SNARE•¡‡‘Ì kn-keyword=SNARE•¡‡‘Ì en-keyword=ƒiƒgƒŠƒEƒ€Ä‹zŽû kn-keyword=ƒiƒgƒŠƒEƒ€Ä‹zŽû END